Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis.
Haddad FG, Sasaki K, Senapati J, Xiao L, Park G, Abuasab T, Venugopal S, Rivera D, Bazinet A, Babakhanlou R, Kim K, Ong F, Desikan S, Pemmaraju N, Loghavi S, Borthakur G, DiNardo C, Abbas HA, Short NJ, Daver N, Jabbour E, Garcia-Manero G, Ravandi F, Kantarjian H, Kadia T.
Haddad FG, et al. Among authors: abuasab t.
JCO Oncol Pract. 2024 Jul 16:OP2400027. doi: 10.1200/OP.24.00027. Online ahead of print.
JCO Oncol Pract. 2024.
PMID: 39013130